Login / Signup

An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study.

Neil William Douglas ThomasZachary BeattieJennifer MarcoeKirsten M WrightNicole SharmaNora MattekHiroko H DodgeKatherine V WildJeffrey A Kaye
Published in: JMIR research protocols (2020)
DERR1-10.2196/17603.
Keyphrases
  • study protocol
  • mild cognitive impairment
  • phase iii
  • randomized controlled trial
  • cross sectional
  • phase ii
  • combination therapy
  • replacement therapy
  • smoking cessation